NRIX peer analysis
Nurix Therapeutics (NRIX) against its competitors: price, today's move, 1-year return and market value side by side.
NRIX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CCCC C4 Therapeutics | $3.14 | 6.44% | 31.01% | – |
| KURA Kura Oncology | $7.27 | 6.91% | -26.66% | $604.93M |
| KYMR Kymera Therapeutics | $131.07 | 2.30% | 115.76% | – |
| RIGL Rigel Pharmaceuticals | $39.65 | -13.26% | 5.15% | $853.86M |
| RVMD Revolution Medicines | $194.38 | 9.41% | 220.19% | $38.42B |
| SNDX Syndax Pharmaceuticals | $9.70 | 3.52% | -35.99% | $843.56M |
| TNGX Tango Therapeutics | $21.50 | 3.02% | 187.62% | – |
| NRIX Nurix Therapeutics | $15.07 | 1.55% | 22.84% | – |
- NRIX's peers: CCCC (C4 Therapeutics), KURA (Kura Oncology), KYMR (Kymera Therapeutics), RIGL (Rigel Pharmaceuticals), RVMD (Revolution Medicines), SNDX (Syndax Pharmaceuticals), TNGX (Tango Therapeutics).
Updated 2026-11-07 11:55 UTC